Prognosis of non-surgically treated, clinical stage I lung cancer patients in Japan

Lung Cancer. 2002 Apr;36(1):65-9. doi: 10.1016/s0169-5002(01)00459-7.

Abstract

Objective: The optimal management of stage I lung cancer is surgical resection. However, some of these patients are not candidates for surgery because of several medical problems. We analyzed prognosis of non-surgically treated, clinical stage I lung cancer patients.

Methods and results: There were 21211 lung cancer patients registered from 1982 to 1991 in the data-base of the Japanese National Chest Hospital Study Group for Lung Cancer, and the number of non-surgically treated, clinical stage I lung cancer patients during the 10 years was 802. The 5- and 10-year survival rates of the 799 patients, exclusive of two carcinoid tumors and one adenid cystic carcinoma which have good prognosis, were 16.6 and 7.4%. We analyzed the 799 patients according to several prognostic factors. Sex, T factor of the tumor, histology, performance status and the method in which lung cancer was detected were prognostic factors, but age and treatment method were not associated with prognosis. Forty-nine patients survived for 5 years or more without surgical resection, but the survival rate continued to decrease even after 5 years, and the 7- and 10- year survival rates were 34.4 and 18.1% in the 49 patients.

Conclusions: It is a fact that there are long-term survivors in non-surgically treated, stage I lung cancer patients. However, the rate is low, and the survival curve continues to decrease even after 5 years. Long-term survivors might suggest the presence of a lung cancer in which the tumor growth is slow.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / mortality
  • Adenocarcinoma / therapy
  • Aged
  • Aged, 80 and over
  • Carcinoma, Large Cell / diagnosis
  • Carcinoma, Large Cell / mortality
  • Carcinoma, Large Cell / therapy
  • Carcinoma, Small Cell / diagnosis
  • Carcinoma, Small Cell / mortality
  • Carcinoma, Small Cell / therapy
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / therapy
  • Female
  • Humans
  • Japan / epidemiology
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / therapy
  • Male
  • Mass Screening
  • Neoplasm Staging
  • Prognosis
  • Survival Rate